A Study of Acalabrutinib vs Investigator's Choice of Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in R/R CLL

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

310

Participants

Timeline

Start Date

February 2, 2017

Primary Completion Date

September 3, 2021

Study Completion Date

October 1, 2027

Conditions
Chronic Lymphocytic Leukemia
Interventions
DRUG

Acalabrutinib (ACP-196)

Acalabrutinib monotherapy

DRUG

Rituximab

Rituximab in combination with idelalisib or bendamustine

DRUG

Idelalisib

Idelalisib in combination with rituximab

DRUG

Bendamustine

Bendamustine in combination with rituximab

Trial Locations (157)

100

Research Site, Taipei

970

Research Site, Hualien City

1122

Research Site, Budapest

1130

Research Site, Vienna

1160

Research Site, Vienna

1307

Research Site, Dresden

2060

Research Site, Antwerp

2217

Research Site, Kogarah

2250

Research Site, Gosford

3000

Research Site, Vratsa

3080

Research Site, Seoul

3112

Research Site, Tauranga

3128

Research Site, Box Hill

3199

Research Site, Frankston

3220

Research Site, Geelong

3722

Research Site, Seoul

4002

Research Site, Plovdiv

4010

Research Site, Linz

4032

Research Site, Debrecen

4101

Research Site, South Brisbane

4442

Research Site, Palmerston North

4600

Research Site, Wels

5000

Research Site, Adelaide

5011

Research Site, Woodville

5020

Research Site, Salzburg

5530

Research Site, Yvoir

5700

Research Site, Gyula

5800

Research Site, Pleven

6000

Research Site, Stara Zagora

6009

Research Site, Nedlands

6150

Research Site, Murdoch

7000

Research Site, Hobart

7400

Research Site, Kaposvár

8011

Research Site, Addington

8900

Research Site, Roeselare

8916

Research Site, Badalona

9000

Research Site, Ghent

9016

Research Site, Dunedin

10002

Research Site, Zhytomyr

10960

Research Site, Nyack

13273

Research Site, Provence Alpes Cote D'Azur

13620

Research Site, Gyeonggi-do

16126

Research Site, Genova

16132

Research Site, Genova

18009

Research Site, Cherkasy

20132

Research Site, Milan

20162

Research Site, Milan

22100

Research Site, Nahariya

24127

Research Site, Bergamo

25123

Research Site, Brescia

28006

Research Site, Madrid

28009

Research Site, Madrid

28031

Research Site, Madrid

28033

Research Site, Madrid

28041

Research Site, Madrid

28222

Research Site, Majadahonda

29000

Research Site, Khmelnytsky

29609

Research Site, Brest

30607

Research Site, Athens

33081

Research Site, Aviano

34295

Research Site, Montpellier

34362

Research Site, Haifa

35000

Research Site, Rennes

37007

Research Site, Salamanca

39008

Research Site, Santander

40353

Research Site, Mount Sterling

41100

Research Site, Modena

41944

Research Site, Daegu

44033

Research Site, Donggu

44093

Research Site, Nantes

44719

Research Site, Canton

46026

Research Site, Valencia

47014

Research Site, Meldola

49102

Research Site, Petah Tikvah

Research Site, Dnipropetrovsk

49241

Research Site, Busan

50134

Research Site, Florence

52403

Research Site, Cedar Rapids

54907

Research Site, Jeonju

56303

Research Site, Saint Cloud

60435

Research Site, Joliet

63739

Research Site, Aschaffenburg

66000

Research Site, Perpignan

68506

Research Site, Lincoln

70403

Research Site, Tainan City

73557

Research Site, Mutlangen

75010

Research Site, Paris

75651

Research Site, Paris

76038

Research Site, Rouen

78234

Research Site, Fort Sam Houston

78665

Research Site, Round Rock

81377

Research Site, München

85224

Research Site, Chandler

89081

Research Site, Ulm

93030

Research Site, Oxnard

97180

Research Site, Luleå

150001

Research Site, Hong Kong

150023

Research Site, Yaroslavl

169608

Research Site, SGP

188770

Research Site, SGP

194044

Research Site, Saint Petersburg

197341

Research Site, Saint Petersburg

217562

Research Site, SGP

249031

Research Site, Obninsk

300053

Research Site, Tula

390000

Research Site, Ryazan

440008

Research Site, Penza

620072

Research Site, Yekaterinburg

630087

Research Site, Novosibirsk

4428164

Research Site, Kfar Saba

7830604

Research Site, Ashkelon

9112001

Research Site, Jerusalem

08724

Research Site, Brick

L4M 6M2

Research Site, Barrie

T2N 2T9

Research Site, Calgary

H3T 1E2

Research Site, Montreal

K1H 8L6

Research Site, Ottawa

S4T 7T1

Research Site, Regina

E2L 4L2

Research Site, Saint John

M4N 3M5

Research Site, Toronto

M5G 2M9

Research Site, Toronto

23 000

Research Site, Zadar

10 000

Research Site, Zagreb

625 00

Research Site, Brno

500 05

Research Site, Nový Hradec Králové

779 00

Research Site, Olomouc

708 52

Research Site, Ostrava Poruba

304 60

Research Site, Plzen - Lochotin

100 34

Research Site, Prague

33076, FR

Research Site, Bordeaux

Unknown

Research Site, Pok Fu Lam

Research Site, Ivano-Frankivsk

Research Site, Kyiv

15-276

Research Site, Bialystok

85-168

Research Site, Bydgoszcz

80-129

Research Site, Gdansk

30-727

Research Site, Krakow

93-510

Research Site, Lodz

20-081

Research Site, Lublin

36-200

Research Site, Woj. Podkarpackie

Unk

Research Site, Sochi

Research Site, Volgograd

833 10

Research Site, Bratislava

040 01

Research Site, Košice

UNK

Research Site, Incheon

413 46

Research Site, Gothenburg

171 76

Research Site, Stockholm

03022

Research Site, Kyiv

B9 5SS

Research Site, Birmingham

CB2 0QQ

Research Site, Cambridge

CT1 3NG

Research Site, Canterbury

LE1 7RH

Research Site, Leicester

SE5 9RS

Research Site, London

ME16 9QQ

Research Site, Maidstone

M20 4BX

Research Site, Manchester

SO16 6YD

Research Site, Southampton

WV10 0QP

Research Site, Wolverhampton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Acerta Pharma BV

INDUSTRY